Welcome to LookChem.com Sign In|Join Free

CAS

  • or

72474-40-9

Post Buying Request

72474-40-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

72474-40-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 72474-40-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,4,7 and 4 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 72474-40:
(7*7)+(6*2)+(5*4)+(4*7)+(3*4)+(2*4)+(1*0)=129
129 % 10 = 9
So 72474-40-9 is a valid CAS Registry Number.

72474-40-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name cis-1-Chloro-2-(4-hydroxyphenyl)-1,2-diphenylethylene

1.2 Other means of identification

Product number -
Other names 4-((Z)-2-Chloro-1,2-diphenyl-vinyl)-phenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:72474-40-9 SDS

72474-40-9Relevant articles and documents

Processes for the Preparation of Zuclomiphene and Intermediates Thereof

-

, (2021/05/21)

The present invention provides processes for the preparation of zuclomiphene, as well as intermediates useful in the preparation thereof. In particular, processes are provided for the carbometallation of diphenylacetylene with a compound of Formula (3) to afford either zuclomiphene or an intermediate which is converted to zuclomiphene.

Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis

-

, (2008/06/13)

The present invention relates to a method of using triaryl-ethylene derivatives in the treatment or prevention bone tissue loss or osteoporosis.

Triarylhaloethylenes as gonadotrophin inhibitors

Palopoli,Feil,Holtkamp,Richardson Jr.

, p. 1333 - 1335 (2007/10/06)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 72474-40-9